Todd Zavodnick
Chief Executive Officer presso Dermavant Sciences Ltd.
Posizioni attive di Todd Zavodnick
Società | Posizione | Inizio | Fine |
---|---|---|---|
Children's Skin Disease Foundation | Director/Board Member | - | - |
Dermavant Sciences, Inc.
Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The private company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018. | Chief Executive Officer | 15/11/2018 | - |
Dermavant Sciences Ltd.
Dermavant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Dermavant Sciences Ltd. is a clinical-stage biopharmaceutical company which focuses on developing and commercializing therapeutics in medical dermatology. The company is developing a pipeline of therapies in medical dermatology and is currently advancing development programs for five product candidates which targets specific unmet needs in two of the immuno-dermatology markets, psoriasis and atopic dermatitis, as well as other large markets, including vitiligo, primary focal hyperhidrosis and acne. The company was founded on September 28, 2015 and is headquartered in London, the United Kingdom. | Director/Board Member | 01/05/2019 | - |
Chief Executive Officer | 01/11/2018 | - |
Storia della carriera di Todd Zavodnick
Precedenti posizioni note di Todd Zavodnick
Società | Posizione | Inizio | Fine |
---|---|---|---|
NOVABAY PHARMACEUTICALS | Director/Board Member | 06/05/2016 | 11/09/2019 |
Independent Dir/Board Member | 06/05/2016 | 11/09/2019 | |
REVANCE THERAPEUTICS, INC. | Corporate Officer/Principal | 02/08/2017 | 09/11/2018 |
ZELTIQ AESTHETICS INC | Corporate Officer/Principal | 01/02/2016 | 01/08/2017 |
Galderma Laboratories LP
Galderma Laboratories LP Pharmaceuticals: MajorHealth Technology Galderma Laboratories LP develops and markets dermatology and prescription products. It also offers treatments for skin conditions such as acne, rosacea, atopic dermatitis, soriasis, melasma and sunspots. Galderma Laboratories was founded in 1961 and is headquartered in Fort Worth, TX. | President | 01/05/2012 | 11/01/2016 |
Alcon Laboratories, Inc.
Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Corporate Officer/Principal | 01/01/1998 | 01/04/2012 |
Allurion Technologies, Inc. (Old)
Allurion Technologies, Inc. (Old) Internet Software/ServicesTechnology Services Allurion Technologies, Inc. develops a treatment for obesity. The firm offers a medical device for obesity that can be delivered and removed without surgery or endoscopy. The company was founded by Shantanu k. Gaur and Samuel G. Levy in 2009 and is headquartered in Natick, MA. | Director/Board Member | 17/10/2017 | - |
Formazione di Todd Zavodnick
Rutgers State University of New Jersey | Undergraduate Degree |
The University of Texas at Austin | Masters Business Admin |
Statistiche
Distribuzione geografica
Stati Uniti | 10 |
Francia | 2 |
Regno Unito | 2 |
Posizioni
Director/Board Member | 4 |
Corporate Officer/Principal | 3 |
Chief Executive Officer | 2 |
Settori
Health Technology | 8 |
Consumer Services | 3 |
Technology Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
REVANCE THERAPEUTICS, INC. | Health Technology |
NOVABAY PHARMACEUTICALS | Health Technology |
Aziende private | 7 |
---|---|
ZELTIQ Aesthetics, Inc.
ZELTIQ Aesthetics, Inc. Medical SpecialtiesHealth Technology ZELTIQ Aesthetics, Inc. is a medical technology company, which focuses on developing and commercializing products. Its product, the coolsculpting system is designed to selectively reduce stubborn fat bulges. The company was founded by Mitchell E. Levinson in 2005 and is headquartered in North Chicago, IL. | Health Technology |
Allurion Technologies, Inc. (Old)
Allurion Technologies, Inc. (Old) Internet Software/ServicesTechnology Services Allurion Technologies, Inc. develops a treatment for obesity. The firm offers a medical device for obesity that can be delivered and removed without surgery or endoscopy. The company was founded by Shantanu k. Gaur and Samuel G. Levy in 2009 and is headquartered in Natick, MA. | Technology Services |
Alcon Laboratories, Inc.
Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Health Technology |
Galderma Laboratories LP
Galderma Laboratories LP Pharmaceuticals: MajorHealth Technology Galderma Laboratories LP develops and markets dermatology and prescription products. It also offers treatments for skin conditions such as acne, rosacea, atopic dermatitis, soriasis, melasma and sunspots. Galderma Laboratories was founded in 1961 and is headquartered in Fort Worth, TX. | Health Technology |
Children's Skin Disease Foundation | |
Dermavant Sciences, Inc.
Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The private company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018. | Health Technology |
Dermavant Sciences Ltd.
Dermavant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Dermavant Sciences Ltd. is a clinical-stage biopharmaceutical company which focuses on developing and commercializing therapeutics in medical dermatology. The company is developing a pipeline of therapies in medical dermatology and is currently advancing development programs for five product candidates which targets specific unmet needs in two of the immuno-dermatology markets, psoriasis and atopic dermatitis, as well as other large markets, including vitiligo, primary focal hyperhidrosis and acne. The company was founded on September 28, 2015 and is headquartered in London, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Todd Zavodnick
- Esperienza